Results 61 to 70 of about 24,341 (292)

Cutaneous and renal glomerular vasculopathy as a cause of acute kidney injury in dogs in the UK [PDF]

, 2015
To describe the signalment, clinicopathological findings and outcome in dogs presenting with acute kidney injury (AKI) and skin lesions between November 2012 and March 2014, in whom cutaneous and renal glomerular vasculopathy (CRGV) was suspected and ...
ARDISSINO, ARDISSINO, ARONSON, BIRNBAUM, BLOMBERY, BOURHY, BOYCE, BURNENS, CARPENTER, CHANTREY, COWAN, DELL'ORCO, DICKINSON, EUBIG, FERRER, FISCHER, FOURNEL, GARCIA, GOLDFARB, GREENE, HENDRICKS, HERTZKE, HOLLOWAY, KAVANAGH, LI, MILFORD, MONAHAN, MOORE, MORRIS, MUNDAY, NORIS, PASS, REBAR, RENTKO, ROBY, ROTERMUND, RUGGENENTI, SALVADORI, SYKES, TANGEMAN, TARR, TARR, UCHIDA, VAN DEN INGH, VICTORIA, WAIKAR, WALKER   +46 more
core   +1 more source

Small-molecule factor D inhibitors selectively block the alternative pathway of complement in paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome

Haematologica, 2017
Paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome are diseases of excess activation of the alternative pathway of complement that are treated with eculizumab, a humanized monoclonal antibody against the terminal complement ...
Xuan Yuan, Eleni Gavriilaki, Jane A. Thanassi, Guangwei Yang, Andrea C. Baines, Steven D. Podos, Yongqing Huang, Mingjun Huang, Robert A. Brodsky   +8 more
doaj   +1 more source

Hemolytic uremic syndrome (HUS) – case report

Journal of Education, Health and Sport, 2020
Introduction Hemolytic uremic syndrome (HUS) is characterized by hemolytic anemia, thrombocytopenia and acute renal failure. In 90% of children, HUS most often develops after an intestinal infection caused by verotoxin-producing E. coli. The remaining 10%
Aleksandra Borkowska, Anna Sobstyl, Aleksandra Chałupnik, Zuzanna Chilimoniuk, Maciej Dobosz, Szymon Marosz   +5 more
doaj   +1 more source

Pathogenesis of Atypical Hemolytic Uremic Syndrome

Journal of Atherosclerosis and Thrombosis, 2019
Atypical hemolytic uremic syndrome (aHUS) is a type of thrombotic microangiopathy (TMA) defined by thrombocytopenia, microangiopathic hemolytic anemia, and renal failure. aHUS is caused by uncontrolled complement activation in the alternative pathway (AP).
Masaomi Nangaku, Hideki Kato, Yoichiro Ikeda, Yoko Yoshida   +3 more
openaire   +4 more sources

Epidemiology of Atypical Hemolytic Uremic Syndrome: A Systematic Literature Review

Clinical Epidemiology, 2020
Atypical hemolytic uremic syndrome (aHUS) is a rare but severe disorder that frequently has a genetic component and results from the overactivation of the alternative complement pathway. As research moves toward improved diagnosis and therapy of aHUS, it
K. Yan, K. Desai, L. Gullapalli, E. Druyts, C. Balijepalli   +4 more
semanticscholar   +1 more source

Atypical Hemolytic Uremic Syndrome: A Case Report [PDF]

Cureus, 2019
Hemoytic uremic syndrome (HUS) is a rare type of thrombotic microangiopathies. Manifestations include thrombocytopenia, microangiopathic hemolytic anemia, and thrombi in small blood vessels. The prognosis is poor. Herein, we present a case of atypical HUS, which is very rare.
Bilal Nadeem, Ateeq Mubarik, Salman Muddassir, Sohaib Khaleel Mohammed, Khudadad Khan   +4 more
openaire   +3 more sources

Thrombotic microangiopathy and associated renal disorders [PDF]

, 2012
Thrombotic microangiopathy (TMA) is a pathological process involving thrombocytopenia, microangiopathic haemolytic anaemia and microvascular occlusion.
Barbour, T, Cohney, S, Hughes, P, Johnson, S   +3 more
core   +1 more source

Case Series of 3 Patients Diagnosed With Atypical Hemolytic Uremic Syndrome Successfully Treated With Steroids, Plasmapheresis, and Rituximab

Canadian Journal of Kidney Health and Disease, 2017
Rationale: Atypical hemolytic uremic syndrome, which has a high probability of chronic kidney disease, morbidity, and mortality, needs to be promptly recognized when patients present with microangiopathic hemolysis.
Jeffery M. Patterson, Lauren Bolster, Loree Larratt   +2 more
doaj   +1 more source

Actualización en síndrome hemolítico urémico atípico: diagnóstico y tratamiento. Documento de consenso. Revisión [PDF]

, 2015
Podeu consultar la versió en castellà del document a: http://dx.doi.org/10.1016/j.nefro.2015.07.005Haemolytic uraemic syndrome (HUS) is a clinical entity defined as the triad of nonimmune haemolytic anaemia, thrombocytopenia, and acute renal failure, in ...
Abarrategui-Garrido, Al-Akash, Alachkar, Allen, Alvarez-Larran, Ardissino, Ardissino, Ardissino, Ariceta, Ariceta, Besbas, Bienaime, Bitzan, Blasco Pelicano, Boyer, Bresin, Bresin, Bruneau, Bu, Burns, Burwick, Campistol, Caprioli, Caprioli, Caprioli, Carr, Chandran, Chatelet, Chatelet, Constantinescu, Contreras, Davin, Davin, De Cordoba, De Serres, Delmas, Delmas, Delvaeye, Donne, Dorresteijn, Dragon-Durey, Dragon-Durey, Dragon-Durey, Durán, Esparza-Gordillo, Esparza-Gordillo, Faas, Faguer, Fakhouri, Fakhouri, Fakhouri, Fakhouri, Fremeaux-Bacchi, Fremeaux-Bacchi, Fremeaux-Bacchi, Fremont, Furlan, Gaber, Garjau, George, Gilbert, Giordano, Goicoechea de Jorge, Greenbaum, Gruppo, Gruppo, Hadaya, Haller, Jalanko, Jodele, Johnson, Jozsi, Kaplan, Kavanagh, Kelly, Kim, Kose, Krid, Lapeyraque, Larrea, Law, Le Quintrec, Le Quintrec, Legault, Legendre, Lemaire, Levi, Lionet, Loirat, Loirat, Loirat, Loirat, Loirat, Mache, Maga, Malina, Mannucci, Michon, Murphy, Naesens, Nester, Neuhaus, Noris, Noris, Nürnberger, Oakes, Ohanian, Ohanian, Ozaltin, Peffault de Latour, Pisoni, Povey, Prescott, Pérez-Caballero, Reynolds, Richards, Richards, Robson, Roman-Ortiz, Rother, Roumenina, Safa, Saland, Saland, Salem, Sallee, Sanchez-Chinchilla, Sellier-Leclerc, Sharma, Siegler, Sullivan, Thajudeen, Tran, Tsai, Tschumi, Venables, Vilalta, Waters, Weitz, Westra, Wilson, Wilson, Zimmerhackl, Zschiedrich, Zuber, Zuber, Zuber, Zuber   +147 more
core   +3 more sources

Molecular bases for the association of FHR-1 with atypical hemolytic uremic syndrome and other diseases

Blood, 2021
Martin Merinero et al delineate the molecular basis for association of mutant factor H–related protein 1 (FHR-1) with atypical hemolytic uremic syndrome (aHUS) and elucidate the interactions between factor H (CFH) and FHR-1 that regulate complement ...
Héctor Martin Merinero, M. Subias, Amaia Pereda, Elena Gómez-Rubio, Lucia Juana Lopez, C. Fernández, E. Goicoechea de Jorge, S. Martín-Santamaría, F. Cañada, S. Rodríguez de Córdoba   +9 more
semanticscholar   +1 more source